Lv7
4870 积分 2023-01-10 加入
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
12小时前
待确认
Longitudinal changes in DNA methylation in IDH-mutant glioma fuel disease progression through altered cell state differentiation
15小时前
已关闭
Vorasidenib improves response to subsequent chemoradiation in a genetically engineered mouse model of IDH-mutant glioma
18小时前
待确认
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial
19小时前
待确认
Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomas
19小时前
待确认
IDH-mutant gliomas arise from glial progenitor cells harboring the initial driver mutation
19小时前
待确认
Evolving cell states and oncogenic drivers during the progression of IDH-mutant gliomas
19小时前
待确认
Insulator dysfunction and oncogene activation in IDH mutant gliomas
20小时前
待确认
Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence
20小时前
待确认
IDH mutation impairs histone demethylation and results in a block to cell differentiation
20小时前
待确认
皖公网安备34019202002308
